Literature DB >> 30764712

Perioperative Intervention by β-Blockade and NF-κB Suppression Reduces the Recurrence Risk of Endometriosis in Mice Due to Incomplete Excision.

Qiqi Long1, Hanxi Zheng1, Xishi Liu1,2, Sun-Wei Guo1,2.   

Abstract

Despite the demonstrated efficacy of surgical treatment of endometriosis, recurrence after surgery still remains a formidable challenge. Surgery, especially when performed repeatedly, decreases ovarian reserve. Clearly, control of recurrence is an unmet medical need. So far nearly all efforts to control recurrence have been devoted to the identification of risk factors, biomarkers, and postoperative medication. One area that has been completely overlooked is the possibility of perioperative intervention. In this study, we tested the hypothesis that perioperative use of a nonspecific β-blocker and/or a nuclear factor-κB (NF-κB) inhibitor can retard the growth of residual endometriotic lesions that are left intact in the primary surgery. We established a mouse model of recurrence due to incomplete lesion removal by deliberately leaving residual lesions intact in the primary excision surgery. One hour before and 24 hours after the surgery, mice were either untreated or treated with andrographolide, propranolol, or both. Two weeks after the primary surgery, all mice were sacrificed and all lesions were excised and evaluated for immunohistochemistry analysis. We found that perioperative use of andrographolide and/or propranolol significantly decelerated the growth of residual lesions that were intentionally left out during the primary surgery. The perioperative intervention also significantly attenuated the generalized hyperalgesia resulting from the presence of residual lesions. It also inhibited the activation of the adrenergic receptor β2 signaling, resulting in reduced angiogenesis, epithelial-mesenchymal transition, fibroblast-to-myofibroblast transdifferentiation as well as NF-κB suppression and progesterone receptor isoform B induction. These data strongly suggest that perioperative use of β-blockers and/or NF-κB inhibitors may reduce the risk of recurrence in endometriosis.

Entities:  

Keywords:  NF-κB inhibitor; endometriosis; perioperative intervention; recurrence; β-blocker

Year:  2019        PMID: 30764712     DOI: 10.1177/1933719119828066

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  6 in total

1.  Activation of α7 nicotinic acetylcholine receptor retards the development of endometriosis.

Authors:  Meihua Hao; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Biol Endocrinol       Date:  2022-06-04       Impact factor: 4.982

2.  Endometriosis and cardiovascular disease.

Authors:  Benjamin Marchandot; Anais Curtiaud; Kensuke Matsushita; Antonin Trimaille; Aline Host; Emilie Faller; Olivier Garbin; Chérif Akladios; Laurence Jesel; Olivier Morel
Journal:  Eur Heart J Open       Date:  2022-02-02

3.  Network Pharmacology Was Used to Predict the Active Components and Prospective Targets of Paeoniae Radix Alba for Treatment in Endometriosis.

Authors:  Yuting Sun; Junhong Cai; Shun Ding; Shan Bao
Journal:  Reprod Sci       Date:  2022-10-18       Impact factor: 2.924

Review 4.  The Pathogenesis of Adenomyosis vis-à-vis Endometriosis.

Authors:  Sun-Wei Guo
Journal:  J Clin Med       Date:  2020-02-10       Impact factor: 4.241

5.  Association of Hypertension and Breast Cancer: Antihypertensive Drugs as an Effective Adjunctive in Breast Cancer Therapy.

Authors:  Yuanyuan Fan; Nazeer Hussain Khan; Muhammad Farhan Ali Khan; M D Faysal Ahammad; Tayyaba Zulfiqar; Razia Virk; Enshe Jiang
Journal:  Cancer Manag Res       Date:  2022-04-01       Impact factor: 3.989

Review 6.  An Update on the Multifaceted Role of NF-kappaB in Endometriosis.

Authors:  Yuanmeng Liu; Jianzhang Wang; Xinmei Zhang
Journal:  Int J Biol Sci       Date:  2022-07-04       Impact factor: 10.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.